GEN vs CHKP vs IDXX

For growth investors, IDEXX Laboratories, Inc.

(IDXX) is the stronger pick with 10. 4% revenue growth year-over-year, versus 3. 6% for Gen Digital Inc. (GEN). Check Point Software Technologies Ltd. (CHKP) offers the better valuation at 11. 9x trailing P/E (10. 9x forward), making it the more compelling value choice. Analysts rate Gen Digital Inc. (GEN) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Check Point Software Technologies Ltd.

(CHKP) is the cheapest at 11. 9x versus IDEXX Laboratories, Inc. at 44. 3x. On forward P/E, Gen Digital Inc. is actually cheaper at 7. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Check Point Software Technologies Ltd. wins at 1. 09x versus Gen Digital Inc. 's 2. 81x — a reasonable growth-adjusted valuation.

Over the past 5 years, IDEXX Laboratories, Inc.

(IDXX) delivered a total return of +8. 6%, compared to -4. 8% for Check Point Software Technologies Ltd. (CHKP). Over 10 years, the gap is even starker: IDXX returned +568. 9% versus CHKP's +39. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Check Point Software Technologies Ltd.

(CHKP) is the lower-risk stock at 0. 36β versus IDEXX Laboratories, Inc. 's 1. 35β — meaning IDXX is approximately 276% more volatile than CHKP relative to the S&P 500. On balance sheet safety, IDEXX Laboratories, Inc. (IDXX) carries a lower debt/equity ratio of 67% versus 4% for Gen Digital Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), IDEXX Laboratories, Inc.

(IDXX) is pulling ahead at 10. 4% versus 3. 6% for Gen Digital Inc. (GEN). On earnings-per-share growth, the picture is similar: Check Point Software Technologies Ltd. grew EPS 29. 0% year-over-year, compared to 8. 4% for Gen Digital Inc.. Over a 3-year CAGR, GEN leads at 12. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Check Point Software Technologies Ltd.

(CHKP) is the more profitable company, earning 38. 8% net margin versus 16. 3% for Gen Digital Inc. — meaning it keeps 38. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEN leads at 40. 9% versus 30. 5% for CHKP. At the gross margin level — before operating expenses — CHKP leads at 85. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Check Point Software Technologies Ltd. (CHKP) is the more undervalued stock at a PEG of 1. 09x versus Gen Digital Inc. 's 2. 81x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Gen Digital Inc. (GEN) trades at 7. 7x forward P/E versus 39. 9x for IDEXX Laboratories, Inc. — 32. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GEN: 63. 6% to $32. 00.

In this comparison, GEN (2.

6% yield) pays a dividend. CHKP, IDXX do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Check Point Software Technologies Ltd.

(CHKP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 36)). Both have compounded well over 10 years (CHKP: +39. 5%, IDXX: +568. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (GEN (Technology) and CHKP (Technology) and IDXX (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: GEN is a mid-cap quality compounder stock; CHKP is a mid-cap deep-value stock; IDXX is a mid-cap quality compounder stock. GEN pays a dividend while CHKP, IDXX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.